REFERENCES
- Hyman L. Epidemiology of AMD. Age-Related Macular Degeneration: Principles and Practice, R G Hampton, P T Nelson. Raven Press, New York 1992; 1–35
- Munoz B, West S K, Rubin G S. Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation Study. Arch Ophthalmol. 2000; 118(6)819–825, [PUBMED], [INFOTRIEVE], [CSA]
- Spencer G. Projections of the population of the United States by age, sex, and race: 1988 to 1989. Current Population Reports. Series P-25. No. 1018, US Bureau of the Census, Washington, DC 1989
- The E ye. Disease Case Control Group. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol. 1992; 110: 1701–1708
- Snow K K, Cote J, Weining Y. Association between reproductive and hormonal factors and age-related maculopathy in postmenopausal women. Am J Ophthalmol. 2002; 134(6)842–848, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Klein B E, Klein R, Jensen S C, Ritter L L. Are sex hormones associated with age-related maculopathy in women? The Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 1994; 92: 289–295, [PUBMED], [INFOTRIEVE], [CSA]
- Klein B E, Klein R, Lee K E. Reproductive exposures, incident age-related cataracts, and age-related maculopathy in women: The Beaver Dam Eye Study. Am J Ophthalmol. 2000; 130(3)322–326, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Vingerling J R, Dielemans I, Witteman J C. Macular degeneration and early menopause: a case control study. Br Med J. 1995; 310(6994)1570–1571
- Age-Related E ye. Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001; 119(10)1417–1436, [CSA]
- West S K, Munoz B, Rubin G S. Function and visual impairment in a population-based study of older adults. The SEE project. Salisbury Eye Evaluation. Invest Ophthalmol Vis Sci. 1997; 38(1)72–82, [PUBMED], [INFOTRIEVE], [CSA]
- Peters A L, Davidson M B, Schriger D L, Hasselblad V. A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycosylated Hemoglobin Levels. J Am Med Assoc. 1996; 276(15)1246–1252, [CROSSREF]
- Bressler N M, Bressler S B, West S K. The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol 1989; 107: 847–852, [PUBMED], [INFOTRIEVE]
- Taylor H R, West S K. The clinical grading of lens opacities. Aust N Z J Ophthalmol. 1989; 17: 81–86, [PUBMED], [INFOTRIEVE]
- West S K, Rosenthal F, Newland H S, Taylor H R. Use of photographic techniques to grade nuclear cataracts. Invest Ophthalmol Vis Sci. 1988; 29: 73–77, [PUBMED], [INFOTRIEVE]
- Hosmer D W, Lemeshow S. Applied Logistic Regression, 2nd Edition. John Wiley and Sons, Inc., New York 2000
- Wang J J, Foran S, Smith W, Mitchell P. Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort. Arch Ophthalmol. 2003; 121(5)658–663, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Griffin J E, Ojeda S R. Textbook of Endocrine Physiology, 2nd Edition. Oxford University Press, New York 1992
- Ogueta S B, Schwartz S D, Yamashita C K, Farber D B. Estrogen receptor in the human eye: influence of gender and age on gene expression. Invest Ophthalmol Vis Sci. 1999; 40(9)1906–1911, [PUBMED], [INFOTRIEVE], [CSA]
- Munaut C, Lambert V, Noel A. Presence of oestrogen receptor type beta in human retina. Br J Ophthalmol. 2001; 85(7)877–882, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Evans J. Age-related macular degeneration. The Epidemiology of Eye Disease, G J Johnson, D C Minassian, R Weale. Chapman and Hall Medical, London 1998
- Subbiah M T, Kessel B, Agrawal M. Antioxidant potential of specific estrogens on lipid peroxidation. J Clin Endocrinol Metab. 1993; 77(4)1095–1097, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Akcay T, Dincer Y, Kayali R. Effects of hormone replacement therapy on lipid peroxides and oxidation system in postmenopausal women. J Toxicol Environ Health A 2000; 59(1)1–5, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]